University of California, San Francisco
| |
Award Total: $37,291,795 |
# of Awards: 135 |
Home Page: |
Investigators
| |
G. Scott Acton , Ph.D. -
Mark Alexander , Ph.D. -
Stacey Anderson , Ph.D. -
Dorothy Apollonio , Ph.D. -
Carol Basbaum , Ph.D. -
Carol Basbaum , Ph.D. -
David Becker , Ph.D. -
Gilles Benichou , Ph.D. -
Neal Benowitz , M.D. -
Neal Benowitz , M.D. -
Lisa Bero , Ph.D. -
Lisa Bero , Ph.D. -
Lisa Bero , Ph.D. -
Lisa Bero , Ph.D. -
Lisa Bero , Ph.D. -
V. Courtney Broaddus , M.D. -
Karin Buser , B.S. -
Karen Butter , M.L. -
Karen Butter , M.L. -
Karen Butter , M.L. -
Karen Butter , M.L. -
Karen Butter , M.L. -
Karen Butter , M.L. -
Karen Butter , M.L. -
Timothy Carmody , Ph.D. -
Timothy Carmody , Ph.D. -
Timothy Carmody , Ph.D. -
Timothy Carmody , Ph.D. -
Timothy Carmody , Ph.D. -
George Caughey , M.D. -
Shweta Choudhry , Ph.D. -
Rik Derynck , Ph.D. -
Penelope Drake , -
Mark Eisner , M.D., M.P.H. -
Mark Eisner , M.D., M.P.H. -
Laura England , Ph.D. -
John Fahy , M.D. -
Beverly Falcon , Ph.D. -
Huizhou Fan , M.D., Ph.D. -
Nancy Ferreyra , -
Walter Finkbeiner , M.D., Ph.D. -
Susan Fisher , Ph.D. -
Susan Fisher , Ph.D. -
Susan Fisher , Ph.D. -
Susan Fisher , Ph.D. -
Brion Fox , S.M., J.D. -
Michelle Freemer , M.D. -
Kathleen Giacomini , Ph.D. -
Michael Givel , Ph.D. -
Jennifer Gorman , M.D., M.P.H. -
Paul Green , Ph.D. -
Greg Greenwood , Ph.D. -
Greg Greenwood , Ph.D. -
Greg Greenwood , Ph.D. -
Jennifer Haas , M.D. -
Bonnie Halpern-Felsher , Ph.D. -
Bonnie Halpern-Felsher , Ph.D. -
Justin Hamilton , Ph.D. -
Robert Hamilton , Ph.D. -
Marc Hellerstein , M.D., Ph.D. -
Peter Hendricks , Ph.D. -
Lillian Hoika , -
Yvonne Huang , M.D. -
Karen Hudmon , Dr.P.H., R.P.H., M.S. -
Gary Humfleet , Ph.D. -
Gary Humfleet , Ph.D. -
Peyton Jacob , Ph.D. -
Peyton Jacob , Ph.D. -
Peyton Jacob , Ph.D. -
Peyton Jacob , Ph.D. -
Richard Charles Jordan , D.D.S., Ph.D. -
Celia Kaplan , DrPH -
Lori Karan , M.D. -
Kehkooi Kee , Ph.D. -
Minji Kim , Ph.D. -
Laura Koth , M.D. -
Deanna Kroetz , Ph.D. -
Theodore Kurtz , M.D. -
Pierre Lee , Ph.D. -
Jon Levine , M.D., Ph.D. -
James Milton Lightwood , Ph.D. -
Ruth Malone , Ph.D., R.N. -
Ruth Malone , Ph.D., R.N. -
Ruth Malone , Ph.D., R.N. -
Ruth Malone , Ph.D., R.N. -
Ruth Malone , Ph.D., R.N. -
Wendy Max , Ph.D. -
Wendy Max , Ph.D. -
Wendy Max , Ph.D. -
Carol McGruder , B.A. -
Carol McGruder , B.A. -
Steve McPhee , M.D. -
Frederick Jia-Pei Miao , M.D., Ph.D. -
Martha Michel , M.S. -
David Morris , M.D. -
Anna-Barbara Moscicki , M.D. -
Ricardo Munoz , Ph.D. -
Ricardo Munoz , Ph.D. -
Ricardo Munoz , Ph.D. -
Cory Nicholas , B.A. -
Thomas Novotny , M.D., MPH -
Jay Paul , Ph.D. -
Eliseo Perez-Stable , M.D. -
Judith Prochaska , Ph.D., M.P.H. -
Judith Prochaska , Ph.D., M.P.H. -
Judith Prochaska , Ph.D., M.P.H. -
Timothy Quinn , M.D. -
Timothy Quinn , M.D. -
Renee Reijo Pera , Ph.D. -
Steven Rosen , Ph.D. -
James Rubenstein , M.D., Ph.D. -
Mark Rubinstein , M.D. -
Stephen Ruoss , M.D. -
Jack Sadowsky , Ph.D. -
Peter Sargent , Ph.D. -
Suzaynn Schick , Ph.D. -
Brian Schmidt , DDS, MD, PhD -
William Seaman , M.D. -
Wen Shi , Ph.D. -
Dikla Shmueli , Ph.D. -
Joel Simon , M.D., M.P.H. -
Joel Simon , M.D., M.P.H. -
Joel Simon , M.D., M.P.H. -
Elizabeth Smith , Ph.D. -
Antoine Snijders , Ph.D. -
Ronald Stall , Ph.D., M.P.H. -
George Su , M.D. -
Hai-Yen Sung , Ph.D. -
Francis Szoka , Ph.D. -
Francis Szoka , Ph.D. -
Janice Tsoh , Ph.D. -
Janice Tsoh , Ph.D. -
Alan Verkman , M.D., Ph.D. -
Esther Hilda Vock , Ph.D. -
Margaret Walsh , MS, EdD -
Margaret Walsh , MS, EdD -
Margaret Walsh , MS, EdD -
Margaret Walsh , MS, EdD -
Yang Xiao , Ph.D. -
Valerie Yerger , ND, MA -
|
Grants
| |
Title |
Cycle [sort] |
Award |
| |
16S rRNA PhyloChip Analysis of Bacterial Communities in COPD |
2008 (Cycle XVII) |
$75,000 |
| |
Investigator(s): Yvonne Huang , M.D. |
17FT-0040 |
| |
A dynamic model of smoking and healthcare expenditures in CA |
2000 (Cycle IX) |
$595,843 |
| |
Investigator(s): Wendy Max , Ph.D. |
9RT-0157 |
| |
A Smokeless Tobacco Cessation Program: High School Athletes |
1995 (Cycle IV) |
$533,923 |
| |
Investigator(s): Margaret Walsh , MS, EdD |
4RT-0068 |
| |
A stage-based scheduled smoking intervention for Chinese |
2005 (Cycle XIV) |
$554,500 |
| |
Investigator(s): Janice Tsoh , Ph.D. |
14RT-0160H |
| |
A web-based support community as a tool for ST cessation |
2003 (Cycle XII) |
$100,000 |
| |
Investigator(s): Margaret Walsh , MS, EdD |
12IT-0169 |
| |
African Americans: NRT or Alternative Medicine for Cessation |
2006 (Cycle XV) |
$285,000 |
| |
Investigator(s): Valerie Yerger , ND, MA |
15KT-0038H |
| |
Airway transcriptome changes in smokers |
2004 (Cycle XIII) |
$99,500 |
| |
Investigator(s): John Fahy , M.D. |
13IT-0097 |
| |
Allosteric Protein Kinase Modulators via Disulfide Trapping |
2008 (Cycle XVII) |
$75,000 |
| |
Investigator(s): Jack Sadowsky , Ph.D. |
17FT-0042 |
| |
An athletic trainer mediated spit tobacco cessation program |
1998 (Cycle VII) |
$490,546 |
| |
Investigator(s): Margaret Walsh , MS, EdD |
7RT-0058 |
| |
Analysis of a nicotine-related receptor binding site |
1997 (Cycle VI) |
$69,218 |
| |
Investigator(s): Laura England , Ph.D. |
6FT-0103 |
| |
Analysis of tobacco industry documents on scientific researc |
2000 (Cycle IX) |
$442,646 |
| |
Investigator(s): Lisa Bero , Ph.D. |
9RT-0193 |
| |
Banning Butts: The Environmental Case |
2008 (Cycle XVII) |
$99,500 |
| |
Investigator(s): Thomas Novotny , M.D., MPH |
17IT-0014 |
| |
Bayview-Hunters Point partnership toward smoking cessation |
2002 (Cycle XI) |
$75,000 |
| |
Investigator(s): Ruth Malone , Ph.D., R.N. |
11BT-1701 |
| |
Bayview-Hunters Point partnership toward smoking cessation |
2002 (Cycle XI) |
$75,000 |
| |
Investigator(s): Carol McGruder , B.A. |
11BT-1701 |
| |
Behavioral epidemiology of tobacco use among gay men |
1998 (Cycle VII) |
$626,433 |
| |
Investigator(s): Greg Greenwood , Ph.D. |
7RT-0013 |
| |
Bupropion for hospital-based smoking cessation |
2003 (Cycle XII) |
$478,065 |
| |
Investigator(s): Joel Simon , M.D., M.P.H. |
12RT-0148 |
| |
Bupropion for smoking cessation |
1998 (Cycle VII) |
$471,154 |
| |
Investigator(s): Joel Simon , M.D., M.P.H. |
7RT-0033 |
| |
Calorigenic and Atherogenic Effects of Smoking and Nicotine |
1995 (Cycle IV) |
$357,492 |
| |
Investigator(s): Marc Hellerstein , M.D., Ph.D. |
4RT-0233 |
| |
Case studies of indoor air regulations: role of research |
1997 (Cycle VI) |
$292,210 |
| |
Investigator(s): Lisa Bero , Ph.D. |
6RT-0025 |
| |
Cellular Defects in Lung caused by Tobacco Smoke |
1995 (Cycle IV) |
$319,013 |
| |
Investigator(s): Alan Verkman , M.D., Ph.D. |
4RT-0072 |
| |
Chromatin Remodeling in Glucocorticoid Resistance of COPD |
2008 (Cycle XVII) |
$60,000 |
| |
Investigator(s): Karin Buser , B.S. |
17DT-0177 |
| |
Chronic bronchitis: pathology of mucin gene expression |
2000 (Cycle IX) |
$147,758 |
| |
Investigator(s): Walter Finkbeiner , M.D., Ph.D. |
9RT-0214A |
| |
Cigarette smoking in HIV-positive populations |
2000 (Cycle IX) |
$74,882 |
| |
Investigator(s): Gary Humfleet , Ph.D. |
9IT-0234 |
| |
Clinical pharmacology of tobacco alkaloids |
2001 (Cycle X) |
$373,408 |
| |
Investigator(s): Peyton Jacob , Ph.D. |
10RT-0215 |
| |
Clinical Pharmacology of Tobacco Alkaloids |
1995 (Cycle IV) |
$393,855 |
| |
Investigator(s): Peyton Jacob , Ph.D. |
4RT-0023 |
| |
Clinical Pharmacology of Tobacco Alkaloids |
2006 (Cycle XV) |
$508,848 |
| |
Investigator(s): Peyton Jacob , Ph.D. |
15RT-0181 |
| |
Clinical pharmacology of tobacco alkaloids |
1998 (Cycle VII) |
$439,882 |
| |
Investigator(s): Peyton Jacob , Ph.D. |
7RT-0104 |
| |
Corporate strategies: design, conduct, publication of resrch |
2004 (Cycle XIII) |
$407,567 |
| |
Investigator(s): Lisa Bero , Ph.D. |
13RT-0108H |
| |
Cotinine Metabolism in Infants and Children |
2006 (Cycle XV) |
$509,473 |
| |
Investigator(s): Neal Benowitz , M.D. |
15RT-0229 |
| |
CSF biomarkers of brain metastases from lung cancer |
2003 (Cycle XII) |
$100,000 |
| |
Investigator(s): James Rubenstein , M.D., Ph.D. |
12IT-0246 |
| |
Current legal issues in tobacco |
1997 (Cycle VI) |
$34,746 |
| |
Investigator(s): Brion Fox , S.M., J.D. |
6FT-0105 |
| |
Curriculum for treating nicotine dependence in psychiatry |
2004 (Cycle XIII) |
$269,243 |
| |
Investigator(s): Judith Prochaska , Ph.D., M.P.H. |
13KT-0152 |
| |
Depression as a predictor of smoking treatment outcome |
2001 (Cycle X) |
$52,467 |
| |
Investigator(s): G. Scott Acton , Ph.D. |
10FT-0248 |
| |
Determinants of smoking among gay & lesbian youth |
2000 (Cycle IX) |
$509,771 |
| |
Investigator(s): Jay Paul , Ph.D. |
9RT-0218 |
| |
Developing policy to reverse cigar trend: roles of media |
1997 (Cycle VI) |
$249,785 |
| |
Investigator(s): Lisa Bero , Ph.D. |
6RT-0026 |
| |
Disproportionate cost of smoking for communities of color |
2004 (Cycle XIII) |
$278,980 |
| |
Investigator(s): Wendy Max , Ph.D. |
13RT-0030 |
| |
Dissemination of the Rx for Change in Psychiatry Curriculum |
2008 (Cycle XVII) |
$439,283 |
| |
Investigator(s): Judith Prochaska , Ph.D., M.P.H. |
17RT-0077 |
| |
Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma |
1994 (Cycle III) |
$389,719 |
| |
Investigator(s): Rik Derynck , Ph.D. |
3RT-0104 |
| |
Dynamics of state tobacco control making |
1999 (Cycle VIII) |
$70,000 |
| |
Investigator(s): Michael Givel , Ph.D. |
8FT-0095 |
| |
Economic Analysis of Smoking Cessation Therapies |
1999 (Cycle VIII) |
$270,206 |
| |
Investigator(s): James Milton Lightwood , Ph.D. |
8RT-0007 |
| |
Economic Impact of Secondhand Smoke for Communities of Color |
2007 (Cycle XVI) |
$216,038 |
| |
Investigator(s): Wendy Max , Ph.D. |
16RT-0075 |
| |
Effect of maternal smoking on early human development |
2003 (Cycle XII) |
$505,975 |
| |
Investigator(s): Susan Fisher , Ph.D. |
12RT-0059 |
| |
Effect of Maternal Smoking on Early Human Development |
2006 (Cycle XV) |
$489,025 |
| |
Investigator(s): Susan Fisher , Ph.D. |
15RT-0037 |
| |
Effect of maternal smoking on human placental development |
1997 (Cycle VI) |
$450,000 |
| |
Investigator(s): Susan Fisher , Ph.D. |
6RT-0304 |
| |
Effect of maternal smoking on human placental development |
2000 (Cycle IX) |
$515,124 |
| |
Investigator(s): Susan Fisher , Ph.D. |
9RT-0112 |
| |
Effect of PDGF inhibition on angiogenesis in lung cancer |
2005 (Cycle XIV) |
$74,500 |
| |
Investigator(s): Beverly Falcon , Ph.D. |
14FT-0152 |
| |
Effect of tobacco toxins on human germ cell development |
2006 (Cycle XV) |
$33,290 |
| |
Investigator(s): Kehkooi Kee , Ph.D. |
15FT-0178 |
| |
Effects of prenatal nicotine exposure on nicotinic receptors |
2000 (Cycle IX) |
$471,654 |
| |
Investigator(s): Peter Sargent , Ph.D. |
9RT-0101 |
| |
Effects of Tobacco Smoke on Mucin Production in Rat Airways |
1995 (Cycle IV) |
$356,400 |
| |
Investigator(s): Carol Basbaum , Ph.D. |
4RT-0210 |
| |
Efficacy of the nicotine patch in adolescents & young adults |
2002 (Cycle XI) |
$69,800 |
| |
Investigator(s): Mark Rubinstein , M.D. |
11FT-0233 |
| |
Environmental tobacco smoke exposure & adult asthma |
2001 (Cycle X) |
$460,032 |
| |
Investigator(s): Mark Eisner , M.D., M.P.H. |
10RT-0108 |
| |
Functions of IRF-1 and Smad3 interaction in lung cancer |
2001 (Cycle X) |
$69,750 |
| |
Investigator(s): Pierre Lee , Ph.D. |
10FT-0141 |
| |
Fusion proteins that convert VEGF into a cell death factor |
2007 (Cycle XVI) |
$100,000 |
| |
Investigator(s): Timothy Quinn , M.D. |
16IT-0009 |
| |
Gene Markers for Hypertension |
1995 (Cycle IV) |
$356,151 |
| |
Investigator(s): Theodore Kurtz , M.D. |
4RT-0362 |
| |
Gene therapy for emphysema |
1997 (Cycle VI) |
$443,179 |
| |
Investigator(s): Francis Szoka , Ph.D. |
6RT-0109 |
| |
How does smoke activate mucin transcription in lung cells? |
1998 (Cycle VII) |
$432,415 |
| |
Investigator(s): Carol Basbaum , Ph.D. |
7RT-0152 |
| |
Human neurophysiology of nicotine analgesia: sex differences |
2000 (Cycle IX) |
$595,994 |
| |
Investigator(s): David Becker , Ph.D. |
9RT-0142 |
| |
Human oocyte development and PAH exposure |
2005 (Cycle XIV) |
$260,944 |
| |
Investigator(s): Renee Reijo Pera , Ph.D. |
14RT-0159 |
| |
Human tryptase gene expression: role in COPD |
2000 (Cycle IX) |
$545,409 |
| |
Investigator(s): George Caughey , M.D. |
9RT-0152H |
| |
Hypnosis for Smoking Relapse Prevention |
2007 (Cycle XVI) |
$509,353 |
| |
Investigator(s): Timothy Carmody , Ph.D. |
16RT-0074 |
| |
Identification on Tumors of Molecular Targets for NK Cells |
1995 (Cycle IV) |
$314,006 |
| |
Investigator(s): William Seaman , M.D. |
4RT-0184 |
| |
Impact of Positive Mood on Self-Control Depletion in Smoking |
2007 (Cycle XVI) |
$75,000 |
| |
Investigator(s): Dikla Shmueli , Ph.D. |
16FT-0050 |
| |
Implementation of California AB 13: smoking ban in bars |
1998 (Cycle VII) |
$315,181 |
| |
Investigator(s): Lisa Bero , Ph.D. |
7RT-0180 |
| |
Innovation to prevent post-partum relapse |
2000 (Cycle IX) |
$75,000 |
| |
Investigator(s): Jennifer Haas , M.D. |
9IT-0192 |
| |
Internet health research center: smoking, Latinos, & the Web |
2004 (Cycle XIII) |
$535,096 |
| |
Investigator(s): Ricardo Munoz , Ph.D. |
13RT-0050H |
| |
IRAK-1 & active TGF-beta: Counter-regulators in emphysema? |
2003 (Cycle XII) |
$69,000 |
| |
Investigator(s): George Su , M.D. |
12FT-0123 |
| |
Liposome targeted chemotherapy to treat lung cancer |
1999 (Cycle VIII) |
$75,000 |
| |
Investigator(s): Francis Szoka , Ph.D. |
8IT-0138 |
| |
Low-Cost Contingency Management for Smoking Cessation |
2008 (Cycle XVII) |
$478,751 |
| |
Investigator(s): Timothy Carmody , Ph.D. |
17RT-0081 |
| |
Macrophage DAP12 pathway in emphysema |
2007 (Cycle XVI) |
$387,237 |
| |
Investigator(s): Laura Koth , M.D. |
16RT-0072 |
| |
Marketing low-tar cigarettes and new harm-reduced products |
2005 (Cycle XIV) |
$74,500 |
| |
Investigator(s): Stacey Anderson , Ph.D. |
14FT-0013 |
| |
MCP-1 and TGFb in pulmonary emphysema |
2002 (Cycle XI) |
$78,241 |
| |
Investigator(s): David Morris , M.D. |
11KT-0223 |
| |
Mechanism of stress effects on weight in nicotine withdrawal |
1998 (Cycle VII) |
$407,019 |
| |
Investigator(s): Jon Levine , M.D., Ph.D. |
7RT-0068 |
| |
Mechanism of TGF-a shedding in lung cancer development |
2003 (Cycle XII) |
$69,600 |
| |
Investigator(s): Yang Xiao , Ph.D. |
12FT-0179 |
| |
Membrane proteins and TGF-alpha/EGFR: a role in lung cancer? |
1999 (Cycle VIII) |
$40,436 |
| |
Investigator(s): Wen Shi , Ph.D. |
8FT-0033 |
| |
Molecular origins of ApoB atherogenic lipoproteins |
2000 (Cycle IX) |
$445,617 |
| |
Investigator(s): Robert Hamilton , Ph.D. |
9RT-0227 |
| |
Molecular predictors of oral cancer development |
2002 (Cycle XI) |
$419,000 |
| |
Investigator(s): Richard Charles Jordan , D.D.S., Ph.D. |
11RT-0141 |
| |
Multibehavioral changes for disease prevention among smokers |
2002 (Cycle XI) |
$69,824 |
| |
Investigator(s): Judith Prochaska , Ph.D., M.P.H. |
11FT-0013 |
| |
Natural history of tobacco addiction in adolescents |
1998 (Cycle VII) |
$499,505 |
| |
Investigator(s): Anna-Barbara Moscicki , M.D. |
7RT-0195 |
| |
Neuroendocrine responses to nicotine: a physiologic probe |
1998 (Cycle VII) |
$225,000 |
| |
Investigator(s): Lori Karan , M.D. |
7KT-0031 |
| |
New methods for searching tobacco industry documents |
2003 (Cycle XII) |
$59,551 |
| |
Investigator(s): Martha Michel , M.S. |
12DT-0186 |
| |
Nicotine May Affect Inflammation |
1999 (Cycle VIII) |
$435,425 |
| |
Investigator(s): Frederick Jia-Pei Miao , M.D., Ph.D. |
8RT-0032 |
| |
Nicotine Metabolism in Families |
1998 (Cycle VII) |
$465,537 |
| |
Investigator(s): Neal Benowitz , M.D. |
7PT-2004 |
| |
Novel Extracellular Sulfatases and Smoke-induced Lung Cancer |
2008 (Cycle XVII) |
$394,380 |
| |
Investigator(s): Steven Rosen , Ph.D. |
17RT-0117 |
| |
Pager-assisted smoking cessation treatment |
2002 (Cycle XI) |
$463,689 |
| |
Investigator(s): Timothy Carmody , Ph.D. |
11RT-0009 |
| |
Pager-cued therapeutic messages for smoking cessation |
1999 (Cycle VIII) |
$74,889 |
| |
Investigator(s): Timothy Carmody , Ph.D. |
8IT-0053A |
| |
Partnerships to reduce smoking among the LGBT community |
2000 (Cycle IX) |
$73,981 |
| |
Investigator(s): Nancy Ferreyra , |
9BT-1401 |
| |
Partnerships to reduce smoking among the LGBT community |
2000 (Cycle IX) |
$73,981 |
| |
Investigator(s): Greg Greenwood , Ph.D. |
9BT-1401 |
| |
Pediatrician training to prevent children's tobacco exposure |
1997 (Cycle VI) |
$133,852 |
| |
Investigator(s): Eliseo Perez-Stable , M.D. |
6RT-0368 |
| |
Peripheral mechanisms of oral cancer pain in a mouse model |
2003 (Cycle XII) |
$265,332 |
| |
Investigator(s): Brian Schmidt , DDS, MD, PhD |
12KT-0166 |
| |
Pharmacogenomics of New Generation Platinums in Lung Cancer |
2008 (Cycle XVII) |
$394,380 |
| |
Investigator(s): Kathleen Giacomini , Ph.D. |
17RT-0126 |
| |
Predictors of Smoking in African American Adolescents |
1997 (Cycle VI) |
$455,536 |
| |
Investigator(s): Mark Alexander , Ph.D. |
6PT-6002H |
| |
Pregnancy complications and chemokine expression in smokers |
1999 (Cycle VIII) |
$24,543 |
| |
Investigator(s): Penelope Drake , |
8DT-0176 |
| |
Prescription For Change |
2001 (Cycle X) |
$11,257 |
| |
Investigator(s): Karen Hudmon , Dr.P.H., R.P.H., M.S. |
10ST-0339 |
| |
Preserving At Risk Tobacco Control Policy Resources |
2008 (Cycle XVII) |
$392,644 |
| |
Investigator(s): Karen Butter , M.L. |
17RT-0089 |
| |
Preserving at-risk tobacco control policy resources |
2004 (Cycle XIII) |
$392,342 |
| |
Investigator(s): Karen Butter , M.L. |
13RT-0100 |
| |
Programmed cell death in cigarette-induced lung disease |
1998 (Cycle VII) |
$371,556 |
| |
Investigator(s): V. Courtney Broaddus , M.D. |
7RT-0051 |
| |
Proposition 99 Archives |
1995 (Cycle IV) |
$40,000 |
| |
Investigator(s): Karen Butter , M.L. |
4SP-0388 |
| |
Proposition 99 Archives |
2000 (Cycle IX) |
$100,000 |
| |
Investigator(s): Karen Butter , M.L. |
9RT-0135 |
| |
Prospective relationship between risk perception & teen toba |
2000 (Cycle IX) |
$224,884 |
| |
Investigator(s): Bonnie Halpern-Felsher , Ph.D. |
9KT-0072 |
| |
Protecting the "hood" against tobacco: cessation project |
2003 (Cycle XII) |
$512,200 |
| |
Investigator(s): Ruth Malone , Ph.D., R.N. |
12AT-1701 |
| |
Protecting the "hood" against tobacco: cessation project |
2003 (Cycle XII) |
$512,200 |
| |
Investigator(s): Carol McGruder , B.A. |
12AT-1701 |
| |
Pulmonary function and genetic variation in smoke metabolism |
2004 (Cycle XIII) |
$23,693 |
| |
Investigator(s): Jennifer Gorman , M.D., M.P.H. |
13KT-0073 |
| |
Reaching and Treating LGBT Smokers: The Internet and NRT |
2006 (Cycle XV) |
$509,201 |
| |
Investigator(s): Gary Humfleet , Ph.D. |
15RT-0165 |
| |
Regulation of epithelial cell polarity and lung disease |
2004 (Cycle XIII) |
$75,000 |
| |
Investigator(s): Minji Kim , Ph.D. |
13FT-0159 |
| |
Relationship of perceived risks and benefits to teen smoking |
2005 (Cycle XIV) |
$532,037 |
| |
Investigator(s): Bonnie Halpern-Felsher , Ph.D. |
14RT-0010H |
| |
Role of GL12 in oral mucosa maintenance and carcinogenesis |
2005 (Cycle XIV) |
$73,485 |
| |
Investigator(s): Antoine Snijders , Ph.D. |
14FT-0011 |
| |
Role of immune defenses in lung cancer therapy |
1997 (Cycle VI) |
$75,000 |
| |
Investigator(s): Gilles Benichou , Ph.D. |
6IT-0211 |
| |
Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis |
1994 (Cycle III) |
$43,318 |
| |
Investigator(s): Stephen Ruoss , M.D. |
3KT-0222 |
| |
Self-hypnosis for smoking cessation |
2001 (Cycle X) |
$413,119 |
| |
Investigator(s): Timothy Carmody , Ph.D. |
10RT-0061 |
| |
Sex differences in nicotine effects on inflammation |
2006 (Cycle XV) |
$410,570 |
| |
Investigator(s): Paul Green , Ph.D. |
15RT-0032 |
| |
Smoking & depression in Chinese vs. non-Chinese |
1999 (Cycle VIII) |
$225,000 |
| |
Investigator(s): Janice Tsoh , Ph.D. |
8KT-0012 |
| |
Smoking and genes as determinants of SLE and RA serverity |
2004 (Cycle XIII) |
$52,662 |
| |
Investigator(s): Michelle Freemer , M.D. |
13KT-0133 |
| |
Smoking cessation and medical care use/costs in a large HMO |
2003 (Cycle XII) |
$337,964 |
| |
Investigator(s): Hai-Yen Sung , Ph.D. |
12RT-0216 |
| |
Smoking Cessation in Vietnamese: A Controlled Trial |
1995 (Cycle IV) |
$429,006 |
| |
Investigator(s): Steve McPhee , M.D. |
4RT-0354 |
| |
Smoking initiation among Chinese and Vietnames adolescents |
1997 (Cycle VI) |
$449,734 |
| |
Investigator(s): Celia Kaplan , DrPH |
6RT-0367 |
| |
Smoking interventions in diverse LGBT communities |
2002 (Cycle XI) |
$30,905 |
| |
Investigator(s): Greg Greenwood , Ph.D. |
11AT-2001 |
| |
Spanish/English web site for smoking cessation trials |
1998 (Cycle VII) |
$450,400 |
| |
Investigator(s): Ricardo Munoz , Ph.D. |
7RT-0057 |
| |
Spanish/English web site for smoking cessation trials |
2001 (Cycle X) |
$519,674 |
| |
Investigator(s): Ricardo Munoz , Ph.D. |
10RT-0326H |
| |
TGF-a: we need it, but too much is bad |
1998 (Cycle VII) |
$69,967 |
| |
Investigator(s): Huizhou Fan , M.D., Ph.D. |
7FT-0076 |
| |
The impact of secondhand smoke exposure on COPD outcomes |
2008 (Cycle XVII) |
$492,890 |
| |
Investigator(s): Mark Eisner , M.D., M.P.H. |
17RT-0101 |
| |
The role of chloride in tobacco-smoke-induced cancer |
1999 (Cycle VIII) |
$30,580 |
| |
Investigator(s): Esther Hilda Vock , Ph.D. |
8FT-0083 |
| |
The role of platelets in atherogenesis in the mouse |
2004 (Cycle XIII) |
$34,769 |
| |
Investigator(s): Justin Hamilton , Ph.D. |
13FT-0144 |
| |
The Smoking Abstinence Questionnaire |
2007 (Cycle XVI) |
$75,000 |
| |
Investigator(s): Peter Hendricks , Ph.D. |
16FT-0049 |
| |
Tobacco cessation: Lake County adolescents |
1999 (Cycle VIII) |
$74,500 |
| |
Investigator(s): Margaret Walsh , MS, EdD |
8AT-2501 |
| |
Tobacco cessation: Lake County adolescents |
1999 (Cycle VIII) |
$74,500 |
| |
Investigator(s): Lillian Hoika , |
8AT-2501 |
| |
Tobacco Control Archives |
1997 (Cycle VI) |
$103,839 |
| |
Investigator(s): Karen Butter , M.L. |
6ST-0455 |
| |
Tobacco Control Archives: Mangini Documents |
1998 (Cycle VII) |
$67,664 |
| |
Investigator(s): Karen Butter , M.L. |
7ST-0199 |
| |
Tobacco Control Digital Library |
1999 (Cycle VIII) |
$514,796 |
| |
Investigator(s): Karen Butter , M.L. |
8RT-0043 |
| |
Tobacco GeneûEnvironment Interactions & Minority Asthmatics |
2006 (Cycle XV) |
$299,500 |
| |
Investigator(s): Shweta Choudhry , Ph.D. |
15KT-0008H |
| |
Tobacco industry analysis of secondhand smoke |
2003 (Cycle XII) |
$70,000 |
| |
Investigator(s): Suzaynn Schick , Ph.D. |
12FT-0144 |
| |
Tobacco Industry Political Strategies After the 1998 MSA |
2006 (Cycle XV) |
$269,000 |
| |
Investigator(s): Dorothy Apollonio , Ph.D. |
15KT-0145 |
| |
Tobacco industry responses to industry-focused campaigns |
2002 (Cycle XI) |
$77,806 |
| |
Investigator(s): Ruth Malone , Ph.D., R.N. |
11RT-0139 |
| |
Tobacco industry targeting of African Americans |
2000 (Cycle IX) |
$99,680 |
| |
Investigator(s): Ruth Malone , Ph.D., R.N. |
9RT-0095 |
| |
Tobacco Industry Targeting of Older Persons |
2007 (Cycle XVI) |
$509,993 |
| |
Investigator(s): Ruth Malone , Ph.D., R.N. |
16RT-0149 |
| |
Tobacco industry use of diet and obesity issues |
2004 (Cycle XIII) |
$267,526 |
| |
Investigator(s): Elizabeth Smith , Ph.D. |
13KT-0081 |
| |
Tobacco smoke and oocyte differentiation from human ES cells |
2006 (Cycle XV) |
$60,000 |
| |
Investigator(s): Cory Nicholas , B.A. |
15DT-0187 |
| |
Transdermal nicotine replacement for hospitalized smokers |
1997 (Cycle VI) |
$451,969 |
| |
Investigator(s): Joel Simon , M.D., M.P.H. |
6RT-0002 |
| |
Transport and disposition of nicotine in the human placenta |
1998 (Cycle VII) |
$333,108 |
| |
Investigator(s): Deanna Kroetz , Ph.D. |
7RT-0025 |
| |
Vascular endothelial growth factor receptor signaling |
2000 (Cycle IX) |
$224,500 |
| |
Investigator(s): Timothy Quinn , M.D. |
9KT-0149 |
|
